What is the recommended management for mesh erosion following a transvaginal mid‑urethral sling?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Mesh Erosion Following Transvaginal Mid-Urethral Sling

Surgical excision via transvaginal approach with complete mesh removal is the definitive treatment for symptomatic mesh erosion after mid-urethral sling placement, as conservative management universally fails and endoscopic approaches have unacceptably high recurrence rates.

Initial Assessment and Diagnosis

When mesh erosion is suspected, perform:

  • Vaginal examination to identify exposed mesh (though only 72% of erosions are detected on physical exam alone) 1
  • Transvaginal ultrasound (TVUS) - has high sensitivity for detecting mesh extrusion and is superior to physical examination 1
  • Cystoscopy for bladder erosions
  • Urethroscopy for urethral perforations

The mean time from initial sling placement to diagnosis of erosion is approximately 10 months, though about half occur within the first year 2.

Location-Specific Management

Vaginal Erosions

Primary approach: Transvaginal surgical excision

  • Remove all exposed mesh material via vaginal approach 3
  • This systematically corrects symptoms (dyspareunia in 100% of cases) 3
  • Expected outcomes:
    • 100% resolution of dyspareunia
    • 57% maintain continence postoperatively 3
    • 7% failure rate (lowest among all approaches) 2

Do not attempt conservative management - it has a 100% failure rate with persistence or recurrence of erosion 2.

Bladder Erosions

Primary approach: Endoscopic excision, but prepare for revision surgery

  • First-line endoscopic treatment is appropriate initially 3
  • Critical caveat: 42% require second surgery due to re-exposure of mesh 3
  • 33% experience recurrent incontinence after treatment 3
  • Transvaginal approach has superior outcomes with only 7.5% failure rate compared to 33% for endoscopic 2

For complex or recurrent cases: Consider transvaginal approach as primary treatment to avoid multiple procedures.

Urethral Erosions

Primary approach: Transvaginal excision with tissue interposition

  • Transvaginal sling resection with tissue interposition carries the lowest risk of erosion recurrence 2
  • Endoscopic approach has 33% failure rate 2
  • Transurethral approach has 7.5% failure rate 2
  • Transvaginal approach has 7% failure rate (best outcome) 2

Presenting symptoms to identify:

  • Severe dysuria (66% of urethral erosions) 3
  • Overactive bladder symptoms
  • Pelvic pain 2

Surgical Principles

What NOT to Do

Never place synthetic mesh if the urethra is inadvertently injured or near fresh urethral incisions 4. This is a well-accepted principle that synthetic mesh should not be placed in proximity to fresh openings into the genitourinary tract, as it affects wound healing and increases perforation risk 4.

Tissue Interposition Technique

After mesh removal, interpose healthy tissue between the urethra and vaginal epithelium to:

  • Reduce recurrence risk
  • Improve healing
  • Create tissue barrier

Expected Outcomes and Counseling Points

Continence After Mesh Removal

Most patients will experience recurrent stress urinary incontinence - this is the primary trade-off 2, 3:

  • 43-57% maintain continence after vaginal erosion repair 3
  • 67% maintain continence after bladder/urethral erosion repair 3
  • Counsel patients preoperatively that repeat anti-incontinence surgery may be needed

Symptom Resolution

  • Dyspareunia: 100% resolution with complete mesh removal 3
  • Pain symptoms: Typically resolve with mesh excision
  • Urinary tract infections: Resolve after bladder erosion treatment

High-Risk Patients Requiring Vigilant Monitoring

Patients at increased risk for mesh erosion who warrant closer surveillance 4:

  • Prior pelvic surgery (highest risk)
  • Diabetes mellitus - higher erosion risk and reduced effectiveness
  • Poor wound healing conditions:
    • Prior radiation therapy
    • Significant vaginal scarring
    • Poor tissue quality
    • Chronic intermittent catheterization

Timing Considerations

  • Early erosions (within first year): Often related to surgical technique or tissue quality
  • Late erosions (>1 year): May indicate chronic tissue breakdown or infection
  • Do not delay definitive treatment once erosion is diagnosed, as conservative management fails universally 2

Complex Cases and Tertiary Referral

Consider referral to tertiary centers for 5:

  • Recurrent erosions after initial repair
  • Multiple compartment involvement
  • Extensive mesh requiring complex excision
  • Concurrent fistula formation

The transvaginal approach remains the gold standard, though emerging robotic techniques (TREATME approach) show promise for complex cases requiring extensive mesh removal 6.

References

Guideline

acr appropriateness criteria® pelvic floor dysfunction in females.

Journal of the American College of Radiology, 2022

Research

Management of iatrogenic urethral foreign body after mid-urethral sling A literature review.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2023

Research

[Erosive complications of mid urethral slings (MUS): 10 years of surgical experience].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2015

Research

Update in management of vaginal mesh erosion.

Current urology reports, 2013

Research

Robot‑assisted surgical management of mid‑urethral sling erosion into the bladder using transperitoneal robotic extensive approach for total mesh excision.

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.